| Members |
targetComponentId |
| pN1b category |
pN1b |
| pN1b: Clinically apparent (macroscopic) metastasis (melanoma of the skin) |
pN1b |
| pN1b: Metastasis in 4 to 7 regional lymph nodes (esophagus) |
pN1b |
| pN1b: Metastasis in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent (breast) |
pN1b |
| pN1b: Metastasis in multiple regional lymph node(s) (exocrine pancreas) |
pN1b |
| pN1b: Metastasis to unilateral, bilateral, or contralateral cervical or superior mediastinal lymph nodes (thyroid) |
pN1b |
| pN1c category |
American Joint Committee on Cancer pN1c (qualifier value) |
| pN1c: Metastasis in 1 to 3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent (breast) |
American Joint Committee on Cancer pN1c (qualifier value) |
| pN1c: Metastasis in more than 7 regional lymph nodes (esophagus) |
American Joint Committee on Cancer pN1c (qualifier value) |
| pN1mi category |
American Joint Committee on Cancer pN1mi (qualifier value) |
| pN1mi(i+): Micrometastasis detected only by immunohistochemistry (breast) |
American Joint Committee on Cancer pN1mi (qualifier value) |
| pN1mi: Micrometastasis (greater than 0.2 mm, none greater than 2.0 mm) (breast) |
American Joint Committee on Cancer pN1mi (qualifier value) |
| pN2 (IVA): Bilateral regional lymph node metastasis (pT1-pT4) (TNM category and FIGO stage) (vulva) |
pN2 |
| pN2 (IVB): Bilateral regional lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vulva) |
pN2 |
| pN2 category |
pN2 |
| pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa (nasopharynx) |
pN2 |
| pN2: Bilateral regional lymph node metastasis (vulva) |
pN2 |
| pN2: Metastasis in 2 to 3 regional nodes or intralymphatic regional metastasis without nodal metastasis (melanoma of the skin) |
pN2 |
| pN2: Metastasis in 4 or more regional lymph nodes (colon/rectum) |
pN2 |
| pN2: Metastasis in 4 to 9 axillary lymph nodes, or in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis (breast) |
pN2 |
| pN2: Metastasis in 7 to 15 regional (perigastric) lymph nodes (stomach) |
pN2 |
| pN2: Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension (urinary bladder, ureter, renal pelvis) |
pN2 |
| pN2: Metastasis in more than one regional lymph node (kidney) |
pN2 |
| pN2: Metastasis in the subcarinal lymph node(s) and/or the ipsilateral internal mammary or mediastinal lymph node(s) (thoracic mesothelioma) |
pN2 |
| pN2: Metastasis in unilateral internal iliac AND/OR inguinal lymph node(s) (anal canal) |
pN2 |
| pN2: Metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes(s) (lung) |
pN2 |
| pN2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or more than 5 nodes positive, none more than 5 cm; or evidence of extranodal extension of tumor (testis) |
pN2 |
| pN2a category |
pN2a |
| pN2a: Clinically occult (microscopic) metastasis (melanoma of the skin) |
pN2a |
| pN2a: Metastasis in 4 to 9 axillary lymph nodes (at least one tumor deposit greater than 2.0 mm) (breast) |
pN2a |
| pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension (upper aerodigestive tract) |
pN2a |
| pN2b category |
American Joint Committee on Cancer pN2b (qualifier value) |
| pN2b: Clinically apparent (macroscopic) metastasis (melanoma of the skin) |
American Joint Committee on Cancer pN2b (qualifier value) |
| pN2b: Metastasis in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis (breast) |
American Joint Committee on Cancer pN2b (qualifier value) |
| pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension (upper aerodigestive tract) |
American Joint Committee on Cancer pN2b (qualifier value) |
| pN2c category |
American Joint Committee on Cancer pN2c (qualifier value) |
| pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension (upper aerodigestive tract) |
American Joint Committee on Cancer pN2c (qualifier value) |
| pN2c: Satellite or in-transit metastasis without nodal metastasis (melanoma of the skin) |
American Joint Committee on Cancer pN2c (qualifier value) |
| pN3 category |
American Joint Committee on Cancer pN3 (qualifier value) |
| pN3: Metastasis in a lymph node(s), more than 6 cm in dimension, and/or to supraclavicular fossa (nasopharynx) |
American Joint Committee on Cancer pN3 (qualifier value) |
| pN3: Metastasis in a lymph node, more than 5 cm in greatest dimension (urinary bladder, ureter, renal pelvis) |
American Joint Committee on Cancer pN3 (qualifier value) |
| pN3: Metastasis in a lymph node, more than 6 cm in greatest dimension (upper aerodigestive tract) |
American Joint Committee on Cancer pN3 (qualifier value) |
| pN3: Metastasis in four or more regional nodes, or matted metastatic nodes, or in-transit metastasis or satellite(s) with metastasis in regional node(s) (melanoma of the skin) |
American Joint Committee on Cancer pN3 (qualifier value) |
| pN3: Metastasis in more than 15 regional (perigastric) lymph nodes (stomach) |
American Joint Committee on Cancer pN3 (qualifier value) |
| pN3: Metastasis in perirectal and inguinal lymph nodes AND/OR bilateral internal iliac AND/OR inguinal lymph nodes (anal canal) |
American Joint Committee on Cancer pN3 (qualifier value) |
| pN3: Metastasis in the contralateral mediastinal, internal mammary, or hilar lymph node(s), and/or the ipsilateral or contralateral supraclavicular or scalene lymph node(s) (thoracic mesothelioma) |
American Joint Committee on Cancer pN3 (qualifier value) |
| pN3: Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes(s) (lung) |
American Joint Committee on Cancer pN3 (qualifier value) |
| pN3: Metastasis with a lymph node mass more than 5 cm in greatest dimension (testis) |
American Joint Committee on Cancer pN3 (qualifier value) |
| pN3a category |
American Joint Committee on Cancer pN3a (qualifier value) |
| pN3a: Metastasis in 10 or more axillary lymph nodes (at least one tumor deposit greater than 2.0 mm), or metastasis to infraclavicular lymph nodes (breast) |
American Joint Committee on Cancer pN3a (qualifier value) |
| pN3a: Metastasis in a lymph node(s), more than 6 cm in dimension (nasopharynx) |
American Joint Committee on Cancer pN3a (qualifier value) |
| pN3b category |
American Joint Committee on Cancer pN3b (qualifier value) |
| pN3b: Metastasis in lymph node(s) residing wholly or in part in the supraclavicular fossa (nasopharynx) |
American Joint Committee on Cancer pN3b (qualifier value) |
| pN3b: Tumor of breast with metastasis as per American Joint Committee on Cancer 6th Edition definition (breast) |
American Joint Committee on Cancer pN3b (qualifier value) |
| pN3c category |
pN3c |
| pN3c: Metastasis in ipsilateral supraclavicular lymph nodes (breast) |
pN3c |
| pNX category |
American Joint Committee on Cancer pNX (qualifier value) |
| pNX: Regional lymph nodes cannot be assessed (e.g., previously removed, or not removed for pathologic study) (breast) |
American Joint Committee on Cancer pNX (qualifier value) |
| pT category finding |
American Joint Committee on Cancer pathological T category allowable value (qualifier value) |
| pT category not identified |
pTX |
| pT0 category |
American Joint Committee on Cancer pT0 (qualifier value) |
| pT0: No evidence of primary tumor (breast) |
American Joint Committee on Cancer pT0 (qualifier value) |
| pT1 (I): Cervical carcinoma confined to uterus (extension to corpus should be disregarded) (TNM category and FIGO stage) (uterine cervix) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1 (I): Tumor confined to corpus uteri (TNM category and FIGO stage) (corpus uteri) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1 (I): Tumor confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension (TNM category and FIGO stage) (vulva) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1 (I): Tumor confined to uterus (TNM category and FIGO stage) (gestational trophoblast) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1 (I): Tumor confined to vagina (TNM category and FIGO stage) (vagina) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1 (I): Tumor limited to ovaries (one or both) (TNM category and FIGO stage) (ovary) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1 (I): Tumor limited to the fallopian tube(s) (TNM category and FIGO stage) (fallopian tube) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1 category |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Melanoma 1.0 mm or less in thickness, with or without ulceration (melanoma of the skin) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Solitary tumor without vascular invasion (liver, including intrahepatic bile ducts) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) (ciliary body and choroid) (uveal melanoma) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor 2 cm or less in greatest dimension (anal canal) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor 2 cm or less in greatest dimension (breast) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor 2 cm or less in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor 2 cm or less in greatest dimension |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor 2 cm or less in greatest dimension (lip and oral cavity) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor 2 cm or less in greatest dimension (oropharynx) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor 2 cm or less in greatest dimension limited to the thyroid (thyroid) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor 2 cm or less in greatest dimension without extraparenchymal extension (major salivary glands) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus) (lung) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor 5 cm or less in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney (kidney) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor 8 cm or less in greatest dimension (bone) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor 8 cm or less in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor confined to the bile duct histologically (extrahepatic bile ducts) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor confined to the nasopharynx (nasopharynx) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor confined to the retina, vitreous, or subretinal space. No optic nerve or choroidal invasion (retinoblastoma) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor invades lamina propria or muscle layer (gallbladder) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor invades lamina propria or submucosa (esophagus) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor invades lamina propria or submucosa (small intestine) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor invades lamina propria or submucosa (stomach) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor invades subepithelial connective tissue (urinary bladder, ureter, renal pelvis) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor invades submucosa (appendix) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor invades submucosa (colon/rectum) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor involves ipsilateral parietal pleura, with or without focal involvement of visceral pleura (thoracic mesothelioma) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor limited to ampulla of Vater or sphincter of Oddi (ampulla of Vater) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor limited to one subsite of hypopharynx and 2 cm or less in greatest dimension (hypopharynx) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor limited to one subsite of supraglottis with normal vocal cord mobility (larynx, supraglottis) |
American Joint Committee on Cancer pT1 (qualifier value) |
| pT1: Tumor limited to the iris (iris) (uveal melanoma) |
American Joint Committee on Cancer pT1 (qualifier value) |
FHIR